Health Trials

ACC

2

Review clinical trials related to ACC. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)

To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ACC or PPGL.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Aug 3, 2026Locations: 1
Eligibility criteria

18 years of age or older. Because no dosing or adverse event data are currently... [+20]

Received cytotoxic chemotherapy (including investigational cytotoxic chemotherap... [+46]

Read more
Status: Recruiting

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced Adrenocortical Carcinoma.

Participants needed: 12
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Apr 15, 2026Locations: 7
Eligibility criteria

Be willing and able to provide written informed consent for the trial. [+12]

Is currently participating in or has participated in a study of an investigation... [+13]

Read more